Trump Health Officials Suppress COVID-19 Vaccine Data, Undermine Public Trust
Former FDA official Vinay Prasad claimed without evidence that 10 children died from COVID-19 vaccines. Meanwhile, NIH and CDC head Jay Bhattacharya b...
Xeber.world
Vinay Prasad
- electric vehicles
- automotive industry
- Stellantis
- collector cars
- automotive history
- Limited Edition
- classic cars
- Mecum Auctions
- supercar
- Formula 1
- Donald Trump
- AI ethics
- U.S. China relations
- AI adoption
- AI regulation
- artificial intelligence
- Trump administration
- inflation
- AI governance
- AI in business
- Bitcoin
- crypto regulation
- Senate Banking Committee
- CLARITY Act
- digital assets
- Digital Asset Market Clarity Act
- Federal Reserve
- Bitcoin price
- Bitcoin ETF
- crypto market
- AI cybersecurity
- cybersecurity
- CISA
- enterprise security
- CVE-2026-41089
- CVE-2026-41096
- Canvas data breach
- Instructure
- House Homeland Security Committee
- Donald Trump
- Netflix
- late-night TV
- Disney
- Paramount
- Cannes Film Festival
- Stephen Colbert
- Prime Video
- Jimmy Kimmel
- Marvel
- climate change
- renewable energy
- energy policy
- AI data centers
- geothermal energy
- Fervo Energy
- U.S. energy policy
- Strait of Hormuz
- Jason Bordoff
- Texas drought
- Subnautica 2
- Phasmophobia
- gaming news
- R.E.P.O.
- Forza Horizon 6
- FC 26
- Subnautica 2 tips
- Subnautica 2 guide
- Alan Wake event
- Destructoid
- FDA
- public health
- Marty Makary
- Trump administration
- healthcare policy
- Kyle Diamantas
- hantavirus
- health policy
- FDA leadership
- gene therapy
- Donald Trump
- Trump administration
- Supreme Court
- gerrymandering
- Iran war
- Voting Rights Act
- 2024 election
- Republican Party
- Virginia Supreme Court
- redistricting
- AI ethics
- climate change
- Elon Musk
- OpenAI
- ChatGPT
- tech industry
- Tesla
- remote sensing
- AI in the workplace
- generative AI
FDA Reverses Rejection of Ebvallo for Rare Blood Cancer After Clinical Trial Review
Pierre Fabre Pharmaceuticals and Atara Biotherapeutics announced that the FDA has reconsidered its rejection of Ebvallo, a therapy for a rare blood ca...
FDA Leadership Shake-Up Sparks Hope in Gene Therapy Sector Amid Rome Conference
Gene therapy leaders gathered in Rome last week, where optimism stemmed from recent rare disease treatment approvals and the impending departure of FD...
FDA Proposes Ban on Compounded Obesity and Diabetes Drugs, Names New Acting Director
The FDA proposed excluding semaglutide and tirzepatide from compounding lists, citing no clinical need. Katherine Szarama was named acting director of...
Katherine Szarama Appointed Acting Director of FDA’s Biologics Center Amid Leadership Transition
The FDA has named Katherine Szarama as the acting director of the Center for Biologics Evaluation and Research. She replaces Vinay Prasad, who left th...